Cargando…

The Cancer-Immune Set Point in Oesophageal Cancer

Immunotherapy has achieved long-term disease control in a proportion of cancer patients, but determinants of clinical benefit remain unclear. A greater understanding of antitumor immunity on an individual basis is needed to facilitate a precision oncology approach. A conceptual framework called the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Power, Robert, Lowery, Maeve A., Reynolds, John V., Dunne, Margaret R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287212/ https://www.ncbi.nlm.nih.gov/pubmed/32582553 http://dx.doi.org/10.3389/fonc.2020.00891

Ejemplares similares

Advances in the curative management of oesophageal cancer
por: Bolger, Jarlath C., et al.
Publicado: (2021)

The intra-class heterogeneity of immunophenotyping and immune landscape in oesophageal cancer and clinical implications
por: Xie, Yujie, et al.
Publicado: (2021)

Impact of radiotherapy on the immune landscape in oesophageal adenocarcinoma
por: Donlon, Noel E, et al.
Publicado: (2022)

Retrospective cohort study on treatment modalities and survival time after oesophageal fistula in patients with oesophageal cancer in a regional cancer care centre in China
por: Xu, Wencai, et al.
Publicado: (2023)

SULF2 expression by immunohistochemistry and overall survival in oesophageal cancer: a cohort study
por: Lui, Natalie Shaubie, et al.
Publicado: (2012)

Exercise-based dysphagia rehabilitation for adults with oesophageal cancer: a systematic review
por: Gillman, Anna, et al.
Publicado: (2022)

The Prognostic Value of the Lymph Node in Oesophageal Adenocarcinoma; Incorporating Clinicopathological and Immunological Profiling
por: Donlon, Noel E., et al.
Publicado: (2021)

Immune Check Point Inhibitors and Immune-Related Adverse Events in Small Cell Lung Cancer
por: Hou, Wanting, et al.
Publicado: (2021)

Identification of Four Immune Subtypes in Bladder Cancer Based on Immune Gene Sets
por: Tang, Chaozhi, et al.
Publicado: (2020)

Risk factors of oesophageal cancer at health facilities in Addis Ababa, Ethiopia: Unmatched case control study
por: Dessalegn, Berhe, et al.
Publicado: (2022)

Impact of fiducial markers placement on the delineation of target volumes in radiation therapy for oesophageal cancer: FIDUCOR study
por: Rochigneux, Philippe, et al.
Publicado: (2022)

Role of cancer-associated fibroblasts in the progression, therapeutic resistance and targeted therapy of oesophageal squamous cell carcinoma
por: Xue, Mengying, et al.
Publicado: (2023)

Development and validation of a prognostic model incorporating texture analysis derived from standardised segmentation of PET in patients with oesophageal cancer
por: Foley, Kieran G, et al.
Publicado: (2017)

Marital status and survival after oesophageal cancer surgery: a population-based nationwide cohort study in Sweden
por: Brusselaers, Nele, et al.
Publicado: (2014)

Detection of Oesophageal Fistula by Radionuclide Salivagram SPECT/CT
por: Wang, Yingwei, et al.
Publicado: (2021)

Visceral adipose tissue secretome from early and late-stage oesophageal cancer patients differentially affects effector and regulatory T cells
por: Davern, Maria, et al.
Publicado: (2023)

Lymphadenectomy and health-related quality of life after oesophageal cancer surgery: a nationwide, population-based cohort study
por: Schandl, Anna, et al.
Publicado: (2016)

Prediction models for venous thromboembolism in ambulatory adults with pancreatic and gastro-oesophageal cancer: protocol for systematic review and meta-analysis
por: Zaheer, Asma, et al.
Publicado: (2022)

18F-FDG PET Radiomics as Predictor of Treatment Response in Oesophageal Cancer: A Systematic Review and Meta-Analysis
por: Deantonio, Letizia, et al.
Publicado: (2022)

Leukaemia inhibitory factor is associated with treatment resistance in oesophageal adenocarcinoma
por: Buckley, Amy M., et al.
Publicado: (2018)

Genotype–phenotype correlation in BRCA1/2 mutation-associated pancreatic cancer
por: Lowery, Maeve A.
Publicado: (2019)

Predicting the response of localised oesophageal cancer to neo-adjuvant chemoradiation
por: Gillham, Charles M, et al.
Publicado: (2007)

Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients
por: Davern, Maria, et al.
Publicado: (2022)

Efficacy and safety of anti-epidermal growth factor receptor agents for the treatment of oesophageal cancer: a systematic review and meta-analysis
por: Zhang, Lijuan, et al.
Publicado: (2021)

Translating evidence in a priority setting partnership: knowledge gaps between healthcare providers and oesophageal cancer patients
por: McDonnell, Sarah, et al.
Publicado: (2023)

The Prostaglandin E2 Pathway and Breast Cancer Stem Cells: Evidence of Increased Signaling and Potential Targeting
por: Walker, Olivia L., et al.
Publicado: (2022)

Enhancement of immune surveillance in breast cancer by targeting hypoxic tumor endothelium: Can it be an immunological switch point?
por: Thomas, Juvin Ann, et al.
Publicado: (2023)

Potential of damage associated molecular patterns in synergising radiation and the immune response in oesophageal cancer
por: Donlon, Noel E, et al.
Publicado: (2023)

Advanced Cancer Imaging Applied in the Comparative Setting
por: Vail, David M., et al.
Publicado: (2020)

Staging of oesophageal cancer
por: Gupta, R., et al.
Publicado: (2015)

What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)? - a retrospective review of the published literature
por: McNamara, Mairéad G, et al.
Publicado: (2022)

Effect of the Rehabilitation Program, ReStOre, on Serum Biomarkers in a Randomized Control Trial of Esophagogastric Cancer Survivors
por: Kennedy, Susan A., et al.
Publicado: (2021)

Short- and Long-Term Outcomes of Totally Versus Hybrid Minimally Invasive Ivor Lewis Oesophagectomy for Oesophageal Cancer: A Propensity Score-Matched Analysis
por: Gu, Yi-Min, et al.
Publicado: (2022)

Prevalence, nature and trajectory of dysphagia postoesophageal cancer surgery: a prospective longitudinal study protocol
por: Hayes, Michelle, et al.
Publicado: (2022)

Metformin is a metabolic modulator and radiosensitiser in rectal cancer
por: Buckley, Croí E., et al.
Publicado: (2023)

Correlation Between Dual-Time-Point FDG PET and Tumor Microenvironment Immune Types in Non-Small Cell Lung Cancer
por: Zhou, Jianyuan, et al.
Publicado: (2021)

The toxicity associated with combining immune check point inhibitors with tyrosine kinase inhibitors in patients with non-small cell lung cancer
por: Kalra, Anjali, et al.
Publicado: (2023)

Oesophageal cancer metastases: An observational study of a more aggressive approach
por: Pickett, Lianne, et al.
Publicado: (2022)

Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers
por: Baxter, Mark A., et al.
Publicado: (2021)

Results of Lung Cancer Screening in a Rural Setting: A Retrospective Cohort Study
por: Bodily, Bridger, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m4576qu0s2qnhsrf78v8v1rrtf